DJIA 17,886.07 81.27 0.46%
NASDAQ 4,768.83 3.45 0.07%
S&P 500 2,070.49 -0.16 -0.01%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

62.07 -3.02 (-4.64%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $62.07 -4.64%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $64.23
Previous Close $65.09
Daily Range $61.10 - $64.97
52-Week Range $22.25 - $67.12
Market Cap $7.3B
P/E Ratio -79.38
Dividend (Yield) $0.00 (0.0%)
Volume 2,711,991
Average Daily Volume 2,925,587
Current FY EPS -$0.53





Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

3 Drugmakers Facing a Pivotal 2015

Isis Pharmaceuticals, PTC Therapeutics, and GW Pharmaceuticals all expect 2015 to be a pivotal year in their drive toward becoming commercially viable entities. Should investors jump in before the catalysts spark?

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape

IWM, HEZU: Big ETF Inflows

Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half

Jim Cramer's Top Stock Picks: BA MMM ISIS Q

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's Post-Market Leader Stock

CNBC's Stock Pops & Drops From December 16

Trade-Ideas: Isis Pharmaceuticals (ISIS) Is Today's "Water-Logged And Getting Wetter" Stock

Value vs. Growth: Is Jim Cramer Right about ISIS Pharmaceuticals?

IWM, QAT: Big ETF Inflows

See More ISIS News...

ISIS's Top Competitors

ISIS $62.07 (-4.64%)
Current stock: ISIS
AMGN $164.76 (-3.18%)
Current stock: AMGN
GILD $93.45 (-13.83%)
Current stock: GILD
BIIB $351.19 (-2.63%)
Current stock: BIIB